Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Morton

Showing results (551-560 of 742) with videos related to

Pageof 75
Sort By:
Advances in Therapy|June 25, 2010
Human monoclonal antibodies to the insulin-like growth factor 1 receptor inhibit receptor activation and tumor growth in preclinical studiesHerbert A Runnels, J Alan Arbuckle, Karen S Bailey, et al.
Urologic Oncology|April 5, 2026
Laboratory paraneoplastic syndrome resolution is associated with reduced recurrence and improved survival in non-metastatic renal cell carcinomaReza Lahiji, Luke L Son, Susan Mumford, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2011
Discovery of ((1S,3R)-1-isopropyl-3-((3S,4S)-3-methoxy-tetrahydro-2H-pyran-4-ylamino)cyclopentyl)(4-(5-(trifluoromethyl)pyridazin-3-yl)piperazin-1-yl)methanone, PF-4254196, a CCR2 antagonist with an improved cardiovascular profileRobert O Hughes, D J Rogier, Rajesh Devraj, et al.
National Science Review|October 25, 2021
Two-dimensional ferromagnetic superlatticesShanshan Liu, Ke Yang, Wenqing Liu, et al.
ACS Nano|February 19, 2019
Ferromagnet/Two-Dimensional Semiconducting Transition-Metal Dichalcogenide Interface with Perpendicular Magnetic AnisotropyWen Zhang, Ping Kwan Johnny Wong, Xiaochao Zhou, et al.
World Journal of Urology|July 6, 2026
Sarcopenia is associated with poor survival among patients with non-metastatic renal cell carcinoma and venous tumor thrombusReza Lahiji, Baris Esen, Luke L Son, et al.
AJR. American Journal of Roentgenology|March 15, 2023
Prospective Pilot Study of <sup>18</sup>F-Fluoroestradiol PET/CT in Patients With Invasive Lobular CarcinomasMatthew F Covington, John M Hoffman, Kathryn A Morton, et al.
European Journal of Cancer (Oxford, England : 1990)|July 10, 2019
Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelinesKetty Peris, Maria Concetta Fargnoli, Claus Garbe, et al.
The British Journal of Dermatology|February 13, 2018
A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF-200 aminolaevulinic acid gel vs. methyl aminolaevulinate cream in the treatment of nonaggressive basal cell carcinoma with photodynamic therapyC A Morton, R Dominicus, P Radny, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2011
Discovery of INCB10820/PF-4178903, a potent, selective, and orally bioavailable dual CCR2 and CCR5 antagonistChangsheng Zheng, Ganfeng Cao, Michael Xia, et al.
Pageof 75

Showing results (551-560 of 742) with videos related to

Sort By:
Pageof 75
Advances in Therapy|June 25, 2010
Human monoclonal antibodies to the insulin-like growth factor 1 receptor inhibit receptor activation and tumor growth in preclinical studiesHerbert A Runnels, J Alan Arbuckle, Karen S Bailey, et al.
Urologic Oncology|April 5, 2026
Laboratory paraneoplastic syndrome resolution is associated with reduced recurrence and improved survival in non-metastatic renal cell carcinomaReza Lahiji, Luke L Son, Susan Mumford, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2011
Discovery of ((1S,3R)-1-isopropyl-3-((3S,4S)-3-methoxy-tetrahydro-2H-pyran-4-ylamino)cyclopentyl)(4-(5-(trifluoromethyl)pyridazin-3-yl)piperazin-1-yl)methanone, PF-4254196, a CCR2 antagonist with an improved cardiovascular profileRobert O Hughes, D J Rogier, Rajesh Devraj, et al.
National Science Review|October 25, 2021
Two-dimensional ferromagnetic superlatticesShanshan Liu, Ke Yang, Wenqing Liu, et al.
ACS Nano|February 19, 2019
Ferromagnet/Two-Dimensional Semiconducting Transition-Metal Dichalcogenide Interface with Perpendicular Magnetic AnisotropyWen Zhang, Ping Kwan Johnny Wong, Xiaochao Zhou, et al.
World Journal of Urology|July 6, 2026
Sarcopenia is associated with poor survival among patients with non-metastatic renal cell carcinoma and venous tumor thrombusReza Lahiji, Baris Esen, Luke L Son, et al.
AJR. American Journal of Roentgenology|March 15, 2023
Prospective Pilot Study of <sup>18</sup>F-Fluoroestradiol PET/CT in Patients With Invasive Lobular CarcinomasMatthew F Covington, John M Hoffman, Kathryn A Morton, et al.
European Journal of Cancer (Oxford, England : 1990)|July 10, 2019
Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelinesKetty Peris, Maria Concetta Fargnoli, Claus Garbe, et al.
The British Journal of Dermatology|February 13, 2018
A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF-200 aminolaevulinic acid gel vs. methyl aminolaevulinate cream in the treatment of nonaggressive basal cell carcinoma with photodynamic therapyC A Morton, R Dominicus, P Radny, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2011
Discovery of INCB10820/PF-4178903, a potent, selective, and orally bioavailable dual CCR2 and CCR5 antagonistChangsheng Zheng, Ganfeng Cao, Michael Xia, et al.
Pageof 75